Clinical studies recruiting near Lawrenceville

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 · North Georgia Rheumatology Group PC · Takeda · NCT06671496 A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · Salveo Integrative Health - Lawrenceville · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404 A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
Phase 3 · Salveo Integrative Health - Lawrenceville · Bristol-Myers Squibb · NCT07288567 A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
Phase 3 · Teak Research Consults · Eli Lilly and Company · NCT07369011 PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
Phase 4 · Parris and Associates Rheumatology · Aurinia Pharmaceuticals Inc. · NCT07611214 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Northside Hospital - Gwinnett · NRG Oncology · NCT05174169 Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · Northside Hospital - Gwinnett · Alliance for Clinical Trials in Oncology · NCT06931340 Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
Phase 3 · Georgia Nephrology Research Inst · Novartis Pharmaceuticals · NCT03955445 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Northside Hospital - Gwinnett · Alliance for Clinical Trials in Oncology · NCT06876714 A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary H
Phase 2/Phase 3 · Physicians Research Associates, LLC /ID# 255675 · AbbVie · NCT06345339 A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Phase 3 · Pfizer · NCT07629440 A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
Phase 3 · Georgia Nephrology · Dimerix Bioscience Pty Ltd · NCT05183646 AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obst
Phase 3 · Physicians Research Associates · Novo Nordisk A/S · NCT07571005 Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIR
Phase 3 · Parris and Associates Rheumatology · Novartis Pharmaceuticals · NCT06133972 A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission o
Phase 3 · Tekton Research Lawrenceville · Hoffmann-La Roche · NCT06094010 Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Phase 3 · Salveo Integrative Health Inc · Intra-Cellular Therapies, Inc. · NCT06372964 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Cornea
Phase 3 · Woolfson Eye Institute · Woolfson Eye Institute · NCT07135167 A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Phase 3 · Teak Research Consults · Eli Lilly and Company · NCT07282600 EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND)
Phase N/A · Capital Health · Natera, Inc. · NCT06808880 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Northside Hospital - Gwinnett · National Cancer Institute (NCI) · NCT05987241 Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
Phase 3 · Ambros Clinical Trial Site · Ambros Therapeutics, Inc. · NCT07210515 Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
Phase 4 · Georgia Nephrology · Calliditas Therapeutics AB · NCT06712407 Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pM
Phase 2/Phase 3 · Georgia Nephrology · Vertex Pharmaceuticals Incorporated · NCT07204275 OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardio
Phase 3 · Georgia Clinical Research · Amgen · NCT07136012 A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirze
Phase 2 · Balanced Life Health Care Solutions/SKYCRNG · Eli Lilly and Company · NCT06897475 Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had
Phase 2/Phase 3 · Northside Hospital - Gwinnett · SWOG Cancer Research Network · NCT06616584 Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Phase 3 · Georgia Nephrology Research Inst · Novartis Pharmaceuticals · NCT04817618 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · Northside Hospital - Gwinnett · National Cancer Institute (NCI) · NCT04267848 A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemi
Phase 2 · Balanced Life Health Care Solutions · Regeneron Pharmaceuticals · NCT07477704

Look up another city

Look up another condition